Acute panmyelosis with myelofibrosis: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import Tags: mobile edit mobile web edit |
||
| Line 67: | Line 67: | ||
[[Category:Acute myeloid leukemia]] | [[Category:Acute myeloid leukemia]] | ||
{{dictionary-stub1}} | {{dictionary-stub1}} | ||
{{No image}} | |||
Revision as of 05:32, 10 February 2025
| Acute panmyelosis with myelofibrosis | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | |
| Pronounce | |
| Field | Hematology, oncology |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Acute panmyelosis with myelofibrosis (APMF) it is a poorly defined disorder that arises as either a clonal disorder, or following toxic exposure to the bone marrow.<ref>,
Hematology: Basic Principles and Practice, 4th edition, Churchill Livingstone, 2004,</ref>
Signs and symptoms
Bone marrow biopsy shows abnormal megakaryocytes, macrocytic erythropoiesis, and defects in neutrophil production and fibrosis of the marrow (myelofibrosis).
Clinically patients present with reduction in the count of all blood cells (pancytopenia), a very few blasts in the peripheral blood and no or little spleen enlargement (splenomegaly).
Cells are usually CD34 positive.<ref name="pmid15578075">,
Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia, Mod. Pathol., Vol. 18(Issue: 5), pp. 603–14, DOI: 10.1038/modpathol.3800348, PMID: 15578075,</ref>
Prognosis and treatment
Median survival is about 9 months. (December 2008)
Autologous stem cell transplantation has been used in treatment.<ref name="pmid17194659">,
Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis, Haematologica, Vol. 91(Issue: 12 Suppl), pp. ECR53, PMID: 17194659, Full text,</ref>
Terminology
Controversy remains today whether this disorder is a subtype of acute myeloid leukemia or myelodysplastic syndromes; however, it is currently classified as a form of AML.<ref>,
Acute panmyelosis with myelofibrosis, Leuk. Lymphoma, Vol. 45(Issue: 4), pp. 681–7, DOI: 10.1080/10428190310001625692, PMID: 15160939, Full text,</ref><ref>, Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up, Ann. Hematol., Vol. 83(Issue: 8), pp. 513–21, DOI: 10.1007/s00277-004-0881-8, PMID: 15173958,</ref>
See also
References
<references group="" responsive="1"></references>
See also
External links
| Myeloid-related hematological malignancy | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
